within Pharmacolibrary.Drugs.C_CardiovascularSystem.C07A_BetaBlockingAgents.C07AB08_Celiprolol;

model Celiprolol
  extends Pharmacolibrary.Drugs.ATC.C.C07AB08;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>C07AB08</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Celiprolol is a selective beta-1 adrenergic receptor antagonist with partial agonist activity at beta-2 receptors. It is used primarily as an antihypertensive agent for the treatment of high blood pressure. Celiprolol is approved for use in several countries, particularly in Europe, but not in the United States.</p><h4>Pharmacokinetics</h4><p>Healthy adult volunteers, mostly male, after single oral dosing.</p><h4>References</h4><ol><li><p>Sonoda, J, et al., &amp; Shimodozono, Y (2021). Impact of green tea intake on the pharmacokinetics of celiprolol in healthy subjects. <i>International journal of clinical pharmacology and therapeutics</i> 59(3) 198–201. DOI:<a href=\"https://doi.org/10.5414/CP203795\">10.5414/CP203795</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33210993/\">https://pubmed.ncbi.nlm.nih.gov/33210993</a></p></li><li><p>Ieiri, I, et al., &amp; Sugiyama, Y (2012). Microdosing clinical study: pharmacokinetic, pharmacogenomic (SLCO2B1), and interaction (grapefruit juice) profiles of celiprolol following the oral microdose and therapeutic dose. <i>Journal of clinical pharmacology</i> 52(7) 1078–1089. DOI:<a href=\"https://doi.org/10.1177/0091270011408612\">10.1177/0091270011408612</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21593283/\">https://pubmed.ncbi.nlm.nih.gov/21593283</a></p></li><li><p>Schmidt, P, et al., &amp; Deutsch, E (1985). [Comparative pharmacokinetics of the beta-1 receptor blookader celiprolol after a single oral administration in subjects with health kidneys and in patients with impaired renal function]. <i>Wiener klinische Wochenschrift</i> 97(18) 729–732. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2866633/\">https://pubmed.ncbi.nlm.nih.gov/2866633</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Celiprolol;
